dc.contributor.author | Svanström, Henrik | |
dc.contributor.author | Ueda, Peter | |
dc.contributor.author | Melbye, Mads | |
dc.contributor.author | Eliasson, Björn | |
dc.contributor.author | Svensson, Ann Mari | |
dc.contributor.author | Franzen, Stefan | |
dc.contributor.author | Gudbjörnsdóttir, Soffia | |
dc.contributor.author | Hveem, Kristian | |
dc.contributor.author | Jonasson, Christian | |
dc.contributor.author | Pasternak, Björn | |
dc.date.accessioned | 2022-03-02T12:47:12Z | |
dc.date.available | 2022-03-02T12:47:12Z | |
dc.date.created | 2019-11-17T16:33:40Z | |
dc.date.issued | 2019 | |
dc.identifier.citation | The Lancet Diabetes and Endocrinology. 2019, 7 (2), 106-114. | en_US |
dc.identifier.issn | 2213-8587 | |
dc.identifier.uri | https://hdl.handle.net/11250/2982510 | |
dc.language.iso | eng | en_US |
dc.publisher | Elsevier | en_US |
dc.title | Use of liraglutide and risk of major cardiovascular events: a register-based cohort study in Denmark and Sweden | en_US |
dc.type | Journal article | en_US |
dc.type | Peer reviewed | en_US |
dc.description.version | publishedVersion | en_US |
dc.rights.holder | The published version of the article will not be available due to copyright restrictions by Elsevier | en_US |
dc.source.pagenumber | 106-114 | en_US |
dc.source.volume | 7 | en_US |
dc.source.journal | The Lancet Diabetes and Endocrinology | en_US |
dc.source.issue | 2 | en_US |
dc.identifier.doi | 10.1016/S2213-8587(18)30320-6 | |
dc.identifier.cristin | 1748412 | |
dc.relation.project | Stiftelsen Kristian Gerhard Jebsen: SKGJ-MED-015 | en_US |
cristin.unitcode | 194,65,20,15 | |
cristin.unitcode | 194,65,20,0 | |
cristin.unitname | Helseundersøkelsen i Nord-Trøndelag | |
cristin.unitname | Institutt for samfunnsmedisin og sykepleie | |
cristin.ispublished | true | |
cristin.qualitycode | 1 | |